Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.
Dec 12, 2018
0
23
In the early 1950's, a 66-year-old woman, sick with colon cancer, received a blood transfusion. Then, unexpectedly, she suffered a severe rejection of the transfused blood. Reporting on her case, the French medical journal ...
Mar 20, 2013
0
0
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...
Oct 19, 2017
0
193
(HealthDay)—Cancer incidence rates have decreased among men but remained stable among women, while cancer death rates are decreasing for both men and women, according to a report published in the July 1 issue of Cancer.
Jul 19, 2018
0
46
In a major triumph for personalized medicine, the FDA approved the drug crizotinib for use with the lung cancer type known as ALK-positive.
Aug 31, 2011
0
0
When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.
May 4, 2018
0
33
Scientists have arrived at a key understanding about how cancers in individual patients spread, or metastasize, a study from the Stanford University School of Medicine and other collaborating institutions reports.
Sep 6, 2018
0
116
To better understand the immune system's role in the fight against cancer, University of North Carolina Lineberger Comprehensive Cancer Center researchers have searched thousands of tumors for genetic signatures that might ...
Aug 25, 2016
0
1
As scientists learn more about which genetic mutations are driving different types of cancer, they're targeting treatments to small numbers of patients with the potential for big payoffs in improved outcomes.
Aug 18, 2016
0
0
Analysis of male- and female-derived tumor samples revealed differences in prognostic biomarkers, genes that drive cancer, and in regulation of key pathways that may predict responses to treatment, according to results published ...
Oct 2, 2018
0
4
